Pentamidine
Sponsors
M.D. Anderson Cancer Center, National Institute of Allergy and Infectious Diseases (NIAID), University of Wisconsin, Madison, University of Maryland, Baltimore, Immtech Pharmaceuticals, Inc
Conditions
African TrypanosomiasisColorectal CancerDiabetes Mellitus, Insulin-DependentHIV-infection/AidsHematologic MalignancyHodgkin LymphomaKidney DiseaseKidney Transplantation
Phase 1
Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults
CompletedNCT00078559
Start: 2003-11-30End: 2010-02-28Updated: 2018-06-29
A Safety Study of Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Chemotherapy as Second-line and/or Third-line Treatment
CompletedNCT00809796
Start: 2008-03-31End: 2011-06-30Target: 15Updated: 2011-06-28
A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy
CompletedNCT00810953
Start: 2009-01-31End: 2011-06-30Updated: 2011-06-28
Pentamidine + Salvage Chemo for Relapsed/Refractory Classical Hodgkin Lymphoma
CompletedNCT03730363
Start: 2018-12-19End: 2019-05-23Updated: 2021-07-07
Phase 2
Islet Transplantation for Type 1 Diabetes
CompletedNCT00014911
Start: 2001-04-30End: 2010-08-31Updated: 2017-03-15
Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
CompletedNCT00002524
Start: 1993-06-30End: 2005-10-31Updated: 2012-07-30
0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma
TerminatedNCT00729807
Start: 2008-07-31End: 2012-11-30Updated: 2019-08-16
Trial of DB289 for the Treatment of Stage I African Trypanosomiasis
CompletedNCT00803933
Start: 2003-02-28End: 2005-06-30Updated: 2008-12-08